N T Maidment

Author PubWeight™ 49.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J Neurosurg 1999 2.46
2 Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A 2009 1.51
3 Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 1993 1.51
4 Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res 1999 1.32
5 Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 1996 1.28
6 Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol Psychiatry 2006 1.24
7 Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem 1999 1.23
8 Concurrent release of ATP and substance P within guinea pig trigeminal ganglia in vivo. Brain Res 2001 1.20
9 Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl) 2001 1.12
10 Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo. Brain Res 2000 1.05
11 Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice. Neuroscience 2001 1.02
12 Excitability properties of medial forebrain bundle axons of A9 and A10 dopamine cells. Brain Res 1988 1.02
13 Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur J Neurosci 2005 1.01
14 Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainate rat model of hippocampal epilepsy. Epilepsy Res 1996 1.01
15 Increased dopamine release in the human amygdala during performance of cognitive tasks. Nat Neurosci 2001 1.00
16 Weak base model of amphetamine action. Ann N Y Acad Sci 1992 0.99
17 Presynaptic versus postsynaptic localization of mu and delta opioid receptors in dorsal and ventral striatopallidal pathways. J Neurosci 1997 0.98
18 A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J Neurochem 2001 0.96
19 Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons. Neuroscience 2006 0.95
20 Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Res 1996 0.94
21 Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition. Neuroscience 2009 0.93
22 Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol 1994 0.89
23 Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol 2001 0.89
24 Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis. Neuroscience 1984 0.89
25 Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Brain Res Mol Brain Res 1995 0.88
26 Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat. Neuroscience 2003 0.88
27 Functional coupling, desensitization and internalization of virally expressed mu opioid receptors in cultured dorsal root ganglion neurons from mu opioid receptor knockout mice. Neuroscience 2004 0.88
28 Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal. Neuroscience 2007 0.88
29 HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy. Exp Neurol 2006 0.87
30 Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Dev Neurosci 1998 0.85
31 Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport 1999 0.84
32 Repeated heroin administration increases extracellular opioid peptide-like immunoreactivity in the globus pallidus/ventral pallidum of freely moving rats. Psychopharmacology (Berl) 1998 0.84
33 Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation. Neuroscience 2004 0.83
34 In vivo voltammetry--present electrodes and methods. Neuroscience 1988 0.82
35 Total sleep deprivation increases extracellular serotonin in the rat hippocampus. Neuroscience 2003 0.82
36 Ultradian sleep-cycle variation of serotonin in the human lateral ventricle. Neurology 2002 0.82
37 Long-term expression of genes in vivo using non-replicating HSV vectors. Gene Ther 1994 0.81
38 Microdialysis reveals a morphine-induced increase in pallidal opioid peptide release. Neuroreport 1995 0.81
39 Orphanin FQ and behavioral sensitization to cocaine. Pharmacol Biochem Behav 1999 0.80
40 Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats. Neurogastroenterol Motil 2012 0.80
41 In vivo voltammetric and behavioural evidence for somatodendritic autoreceptor control of mesolimbic dopamine neurones. Brain Res 1985 0.80
42 Opioid regulation of pallidal enkephalin release: bimodal effects of locally administered mu and delta opioid agonists in freely moving rats. J Pharmacol Exp Ther 1998 0.79
43 Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis. J Neurochem 1997 0.79
44 Profiles of extracellular amino acid changes in focal cerebral ischaemia: effects of mild hypothermia. Neurol Res 1993 0.79
45 Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol 2000 0.79
46 Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry. Neuropharmacology 1987 0.78
47 Nociceptin/orphanin FQ modulation of rat midbrain dopamine neurons in primary culture. Neuroscience 2004 0.78
48 Opioid peptide release in the rat hippocampus after kainic acid-induced status epilepticus. Hippocampus 2003 0.77
49 Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry. Eur J Pharmacol 1987 0.77
50 Extracellular glutamate in the dorsal horn of the lumbar spinal cord in the freely moving rat during hindlimb stepping. Pharmacol Biochem Behav 1999 0.77
51 Gabapentin modifies extracellular opioid peptide content in amygdala: a microdialysis study. Epilepsy Res 1999 0.76
52 Microdialysis reveals changes in extracellular opioid peptide levels in the amygdala induced by amygdaloid kindling stimulation. Exp Neurol 1994 0.75
53 Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum. Brain Res 1984 0.75
54 Pemoline produces ipsilateral turning behavior in unilateral 6-OHDA-lesioned rats. Prog Neuropsychopharmacol Biol Psychiatry 1996 0.75
55 Application of intracerebral dialysis and in vivo voltammetry to pharmacological and physiological studies of amine neurotransmitters. Ann N Y Acad Sci 1986 0.75
56 Post-mortem dopamine dynamics assessed by voltammetry and microdialysis. Brain Res Bull 1990 0.75
57 Basal total opioid peptide release in the striatum of rats with cholestasis from bile duct resection: a study by the use of in vivo microdialysis. Life Sci 1997 0.75
58 Opioid peptide systems following a subconvulsant dose of pentylenetetrazol in rats. Epilepsy Res 1999 0.75
59 Opioid peptide release and mu-receptor binding during amygdala kindling in rats: regional discordances. Epilepsy Res Suppl 1996 0.75